Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Wagner F Gattaz, Ricardo Saracco-Alvarez, Claudiane Salles Daltio, Martinus T Van de Bilt, Jose Julian Ortegón, Sergio J Villaseñor-Bayardo, Mario Louzã, Helio Elkis, Bernardo Soares, Patricia Cabrera Jaramillo, Fabio Lawson & Leonardo Díaz-Galvis. (2020) Treatment of Patients with Recently Exacerbated Schizophrenia with Paliperidone Palmitate: A Pilot Study of Efficacy and Tolerability. Neuropsychiatric Disease and Treatment 16, pages 2063-2072.
Read now
Read now
Jingping Zhao, Lehua Li, Jianguo Shi, Yi Li, Xiufeng Xu, Keqing Li, Lili Zhang, Shangli Cai, Yu Feng, Jianmin Zhuo, Weihong Liu & Huafei Lu. (2017) Safety and efficacy of paliperidone palmitate 1-month formulation in Chinese patients with schizophrenia: a 25-week, open-label, multicenter, Phase IV study. Neuropsychiatric Disease and Treatment 13, pages 2045-2056.
Read now
Read now
Tianmei Si, Jianmin Zhuo, Ibrahim Turkoz, Maju Mathews, Wilson Tan & Yu Feng. (2017) Once-monthly injection of paliperidone palmitate in patients with recently diagnosed and chronic schizophrenia: a post-hoc comparison of efficacy and safety. Expert Opinion on Pharmacotherapy 18:17, pages 1799-1809.
Read now
Read now
Bernardo Carpiniello & Federica Pinna. (2016) Critical appraisal of 3-monthly paliperidone depot injections in the treatment of schizophrenia. Drug Design, Development and Therapy 10, pages 1731-1742.
Read now
Read now
Alexandre González-Rodríguez, Rosa Catalán, Rafael Penadés, Clemente Garcia-Rizo, Miquel Bioque, Eduard Parellada & Miquel Bernardo. (2015) Profile of paliperidone palmitate once-monthly long-acting injectable in the management of schizophrenia: long-term safety, efficacy, and patient acceptability – a review. Patient Preference and Adherence 9, pages 695-706.
Read now
Read now
Fan Zhang, Tianmei Si, Chiun-Fang Chiou, Anthony WF Harris, Chang Yoon Kim, Padmashree Jahagirdar & Steve Ascher. (2015) Efficacy, safety, and impact on hospitalizations of paliperidone palmitate in recent-onset schizophrenia. Neuropsychiatric Disease and Treatment 11, pages 657-668.
Read now
Read now
Articles from other publishers (2)
Alexander Keenan, Dee Lin, Jason Shepherd, Hollie Bailey, Carmela Benson & Sophie Meakin. (2022) Patient-psychiatrist discordance and drivers of prescribing long-acting injectable antipsychotics for schizophrenia management in the real-world: a point-in-time survey. BMC Psychiatry 22:1.
Crossref
Crossref
Gülay TAŞCI & Filiz ÖZSOY. (2022) Depo antipsikotik kullanan hastalarda prolaktin düzeyi, cinsel fonksiyon, vücut kitle indeksi ve karaciğer fonksiyon testlerinin karşılaştırılmasıComparison of prolactin level, sexual function, body mass index, and liver function tests in patients using depot antipsychotics. Cukurova Medical Journal 47:3, pages 1172-1178.
Crossref
Crossref